Are you Dr. Kirsch?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
751 S Bascom Ave
Pulmonary Department
San Jose, CA 95128Phone+1 408-885-2050
Summary
- Dr. Carl Kirsch, MD is a pulmonologist in San Jose, California. He is currently licensed to practice medicine in California, Oregon, and Hawaii. He is affiliated with Santa Clara Valley Medical Center and is a Clinical Professor of Medicine at Stanford University.
Education & Training
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1977 - 1979
- Boston University Medical CenterResidency, Internal Medicine, 1976 - 1977
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Psychiatry, 1968 - 1971
- SUNY Downstate Health Sciences UniversityInternship, Transitional Year, 1965 - 1966
- New York University School of MedicineClass of 1965
Certifications & Licensure
- OR State Medical License 1978 - Present
- CA State Medical License 1981 - 2026
- HI State Medical License 1967 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 45 citationsInvasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature.Melisa M Shah, Eric Hsiao, Carl M. Kirsch, Amit Gohil, Supriya Narasimhan
Diagnostic Microbiology and Infectious Disease. 2018-06-01 - 8 citationsFDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review.Dirk Hellwig, Richrad P Baum, Carl Kirsch
Nuklearmedizin. Nuclear Medicine. 2009-01-01 - 1 citationsPara-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.D Hellwig, E Gouverneur, A Schaefer, J Raedle, M Menges
Nuklearmedizin. Nuclear Medicine. 2008-01-01